BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature–positive castration-resistant prostate cancer
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci180378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Shipra Shukla und 20 weiteren Autor:innen. Beteiligte Einrichtung: Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Transcription Factors, Transcriptome, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Urology, University of Washington, Seattle, Washington, USA.
- Weill Cornell Medicine, New York, New York, USA.
- Weill Cornell Medical College, New York, New York, USA.
- Zenith Epigenetics, Calgary, Alberta, Canada.
- Triana Biomedicines, Waltham, Massachusetts.
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Shukla, S., Li, D., Cho, W. H., Schoeps, D. M., Nguyen, H. M., Conner, J. L., Roskes, M. L., Tehim, A., Bayshtok, G., Pachai, M. R., Yan, J., Teri, N. A., Campeau, E., Attwell, S., Trojer, P., Ostrovnaya, I., Gopalan, A., Khurana, E., Corey, E., …, & Chen, Y. (2025). BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature–positive castration-resistant prostate cancer. Journal of Clinical Investigation. https://doi.org/10.1172/jci180378
Vancouver
Shukla S, Li D, Cho WH, Schoeps DM, Nguyen HM, Conner JL, et al. BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature–positive castration-resistant prostate cancer. Journal of Clinical Investigation. 2025. doi:10.1172/jci180378
BibTeX
@article{Shukla2025,
author = {Shukla, Shipra and Li, Dan and Cho, Woo Hyun and Schoeps, Dana M and Nguyen, Holly M and Conner, Jennifer L and Roskes, Marjorie L and Tehim, Anisha and Bayshtok, Gabriella and Pachai, Mohini R and Yan, Juan and Teri, Nicholas A and Campeau, Eric and Attwell, Sarah and Trojer, Patrick and Ostrovnaya, Irina and Gopalan, Anuradha and Khurana, Ekta and Corey, Eva and Chi, Ping and Chen, Yu},
title = {BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature–positive castration-resistant prostate cancer},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci180378}
}
EUVIMED